1 Start 2 Complete

After attending this session I can now demonstrate the identified learning objectives *

	Yes	No
Recognize that each cysteinyl leukotriene has a distinct receptor preference and cell target	Recognize that each cysteinyl leukotriene has a distinct receptor preference and cell target - Yes	Recognize that each cysteinyl leukotriene has a distinct receptor preference and cell target - No
Recognize the role of cysLTs as polyclonal activators of T cells and innate lymphoid cells	Recognize the role of cysLTs as polyclonal activators of T cells and innate lymphoid cells - Yes	Recognize the role of cysLTs as polyclonal activators of T cells and innate lymphoid cells - No
Identify the epithelial targets of the cysLTs and their role in type 2 immunity	Identify the epithelial targets of the cysLTs and their role in type 2 immunity - Yes	Identify the epithelial targets of the cysLTs and their role in type 2 immunity - No

The session format and teaching technique were appropriate for the content. *

Yes

No

This session met my expectations based on the session description and learning objectives. *

Yes

No

I observed objective, balanced content that demonstrated no bias in favor of goods or services of a commercial interest. *

Yes

No

Speaker/Moderator was engaging and provided accurate, valuable content *

	Yes	No
Patricia A. Takach, MD, FAAAAI	Patricia A. Takach, MD, FAAAAI - Yes	Patricia A. Takach, MD, FAAAAI - No
Elina Jerschow, MD FAAAAI	Elina Jerschow, MD FAAAAI - Yes	Elina Jerschow, MD FAAAAI - No
Anand Kumar Andiappan, PhD	Anand Kumar Andiappan, PhD - Yes	Anand Kumar Andiappan, PhD - No
Kathleen M. Buchheit, MD	Kathleen M. Buchheit, MD - Yes	Kathleen M. Buchheit, MD - No

If you responded no to any questions, or have other comments about this session, please explain.

Please provide any additional feedback about the faculty in this session:

Leave this field blank